A Search Service for Abbreviation / Long Form

■ Related PubMed/MEDLINE Info.

[Related PubMed/MEDLINE]
Total Number of Papers: 146
[Display Entries]
100 entries :
      (Publication year, Descending)
100 entries :
      (Publication year, Ascending)
all entries
[Entries Per Page]
 per page
Page Control
Page: of
Abbreviation : LCQ
Long Form : Leicester Cough Questionnaire
No. Year Title Co-occurring Abbreviation
2022 Assessment of Acupoint Therapy of Traditional Chinese Medicine on Cough Variant Asthma: A Meta-analysis. CVA, RCTs
2022 Characteristics of different asthma phenotypes associated with cough: a prospective, multicenter survey in China. CA, CPA, CVA, FeNO
2022 Clinical significance and safety of combined treatment with chemotherapy and pulmonary rehabilitation regarding health-related quality of life and physical function in nontuberculous mycobacterial pulmonary disease. CAT, CCS, HRQoL, ISWD, NTM-PD, PR
2022 Cough desensitization treatment: A randomized, sham-controlled pilot trial for patients with refractory chronic cough. BCST, RCC, UTC
2022 Cough-Specific Quality of Life Predicts Disease Progression Among Patients With Interstitial Lung Disease: Data From the Pulmonary Fibrosis Foundation Patient Registry. HR, ILD, QoL
2022 Demographic, clinical, and patient-reported outcome data from 2 global, phase 3 trials of chronic cough. HARQ, QoL, VAS
2022 Effect of exercise-based pulmonary rehabilitation in patients with bronchiectasis: A meta-analysis. 6MWD, CI, FEV1, ISWD, MD, RCTs, SGRQ
2022 Effectiveness and Safety of Codeine and Levodropropizine in Patients With Chronic Cough. CSS, VAS
2022 Efficacy and Safety of GHX02 in the Treatment of Acute Bronchitis and Acute Exacerbation of Chronic Bronchitis: A Phase Ⅱ, Randomized, Double-Blind, Placebo-Controlled, Multicenter Trial. AECB, BSS, IMOS, IMPSS, QCSCS
10  2022 Impaired cough-related quality of life in patients with nontuberculous mycobacteriosis. CASA-Q, GERD, NTM, QoL
11  2022 Leicester Cough Questionnaire validation and clinically important thresholds for change in refractory or unexplained chronic cough. CC, PGIC
12  2022 Lymph Node Dissection Is a Risk Factor for Short-Term Cough after Pulmonary Resection. SCS
13  2022 Normative Values for the Leicester Cough Questionnaire in Healthy Individuals. ---
14  2022 Oscillatory positive expiratory pressure therapy in COPD (O-COPD): a randomised controlled trial. O-COPD, OPEP
15  2022 Quantitative evaluation of disease severity in connective tissue disease-associated interstitial lung disease by dual-energy computed tomography. CTD-ILD, DECT, FVC, HRCT, MCS, MCTN, ROC, SF-36, TEI
16  2021 "A Major Quality of Life Issue": A Survey-Based Analysis of the Experiences of Adults With Laryngotracheal Stenosis with Mucus and Cough. ---
17  2021 Abnormal FeV1 and body mass index are associated with impaired cough-related quality of life in sarcoidosis patients. ---
18  2021 Antitussive Effect of a Chest Band in Patients with Interstitial Lung Disease: The Preliminary Results from a Pre-post Intervention Study. CTD-ILD, IIPs, ILD, VAS
19  2021 Azithromycin for the Treatment of Chronic Cough in Idiopathic Pulmonary Fibrosis: A Randomized Controlled Crossover Trial. IPF, SD, VAS
20  2021 Bronchoscopic airway clearance therapy for acute exacerbations of bronchiectasis. B-ACT, CAT
21  2021 Characterization of Patients With Refractory or Unexplained Chronic Cough Participating in a Phase 2 Clinical Trial of the P2X3-Receptor Antagonist Gefapixant. CSD, CSD, GERD, RCC, UCC, VAS
22  2021 Cross-cultural adaptation and validation of the Norwegian version of the Leicester Cough Questionnaire in chronic obstructive pulmonary disease. COPD, PROM
23  2021 Effects of pain on depression, sleep, exercise tolerance, and quality of life in patients with nontuberculous mycobacterial pulmonary disease. BP, CES-D, ISWT, mMRC, NTM-PD, PSQI
24  2021 Evaluation and Management Outcomes and Burdens in Patients with Refractory Chronic Cough Referred for Behavioral Cough Suppression Therapy. BCST, RCC, SLP
25  2021 Exercise training for bronchiectasis. CI, MCID, MD, MDs, SGRQ
26  2021 Flupentixol/melitracen for chronic refractory cough after treatment failure with other neuromodulators. CRC, CSS, HARQ
27  2021 Herbal Medicine for Adult Patients with Cough Variant Asthma: A Systematic Review and Meta-Analysis. CSS, CVA, RCTs, VAS
28  2021 Is laryngeal hypersensitivity the basis of unexplained or refractory chronic cough? DI, RCC, UCC, VHI
29  2021 Long-Term Treatment Outcomes after Behavioral Speech Therapy for Chronic Refractory Cough. BST, CRC
30  2021 Psychometrics of health-related quality of life questionnaires in bronchiectasis: a systematic review and meta-analysis. BHQ, COPD, CRDQ, HRQoL, MCID, QOL-B, SGRQ, SOLQ
31  2021 Safety and efficacy of gefapixant, a novel drug for the treatment of chronic cough: A systematic review and meta-analysis of randomized controlled trials. CI, MD, RCTs, RR
32  2021 The Multidimensional Cough Index: A Practical Scale to Measure Cough and Sputum. AE, VAS
33  2021 Validation of a visual analog scale for assessing cough severity in patients with chronic cough. CSD, PGIC, VAS
34  2021 Validation of the Japanese version of the Manchester Cough in Lung Cancer Scale. MCLCS, QoL, VAS
35  2021 Validation of the Japanese version of the Manchester Cough in Lung Cancer Scale. MCLCS, QoL, VAS
36  2020 A prospective safety and feasibility study of metered cryospray for patients with chronic bronchitis in COPD. CAT, MCS, SGRQ
37  2020 A Randomized, Controlled, Pilot Study of CPAP for Patients with Chronic Cough and Obstructive Sleep Apnea. CPAP, OSA
38  2020 Benign Vocal Fold Lesions in Patients with Chronic Cough. BVFLs, IQR
39  2020 Chronic cough related to the upper airway cough syndrome: one entity but not always the same. AR, CC, CRS, NAR, UACS
40  2020 Effect of short-term inhalation of warm saline atomised gas on patients with non-cystic fibrosis bronchiectasis. 6MWD, UNW
41  2020 Impact of hypertonic saline nebulisation combined with oscillatory positive expiratory pressure on sputum expectoration and related symptoms in cystic fibrosis: a randomised crossover trial. CASA-Q, CF, CI, oscillatory-PEP
42  2020 Incidence and risk factor for short term postoperative cough after thyroidectomy. ---
43  2020 Is the Leicester Cough Questionnaire useful for nontuberculous mycobacterial lung disease? COPD, HRQoL, NTM-LD, SGRQ
44  2020 Minimal Clinically Important Differences for Patient-Reported Outcome Measures of Cough and Sputum in Patients with COPD. CASA-Q, COPD, MCIDs, PR, SEM
45  2020 Patient-Reported Burden of Chronic Cough in a Managed Care Organization. CC, CQLQ, HARQ
46  2020 Predicting Obstructive Sleep Apnea Status With the Reflux Symptom Index in a Sleep Study Population. BMI, OSA, RSI
47  2020 Predictors of cough-specific and generic quality of life in sarcoidosis patients. DAL, FAS, QoL, SACE
48  2020 Quantitative measurement properties and score interpretation of the Cough Severity Diary in patients with chronic cough. CSD, PGIC, RCC/UCC, VAS
49  2020 The efficacy and safety of azithromycin in chronic respiratory diseases related cough. MD, RCTs, VAS
50  2020 The efficacy of inhaled hypertonic saline for bronchiectasis: a meta-analysis of randomized controlled studies. RCTs
51  2019 Association between postoperative cough and thyroidectomy: a prospective study. ---
52  2019 Comparison of therapeutic effects of inhaled corticosteroids on three subtypes of cough variant asthma as classified by the impulse oscillometry system. BUD, CVA, FP, ICSs, IOS, MF
53  2019 Cough-Related Laryngeal Sensations and Triggers in Adults With Chronic Cough: Symptom Profile and Impact. VAS
54  2019 Idiopathic chronic productive cough and response to open-label macrolide therapy: An observational study. HRCT
55  2019 Improved cough- and sputum-related quality of life after initiation of treatment in pulmonary tuberculosis. CASA-Q, QoL, TB
56  2019 Pulmonary rehabilitation after exacerbation of bronchiectasis: a pilot randomized controlled trial. PR, SC
57  2019 Risk factors for repetitive doctor's consultations due to cough: a cross-sectional study in a Finnish employed population. aOR
58  2019 Speech and language therapy for management of chronic cough. CI, HRQoL, MDs, ORs, PSALTI, RCTs, SAEs, SLT, UCC
59  2018 Are chronic cough and laryngopharyngeal reflux more common in obstructive sleep apnea patients? AHI, LPR, OSA, RSI
60  2018 Assessing referral and practice patterns of patients with chronic cough referred for behavioral cough suppression therapy. BCST, RCC
61  2018 Effect of different thoracic anesthesia on postoperative cough. DLT, VAS
62  2018 Efficacy and Safety of Levocloperastine in the Treatment of Dry Cough: A Prospective Observational Study. ADRs, MID, QoL
63  2018 Impact of Hypertonic Saline Solutions on Sputum Expectoration and Their Safety Profile in Patients with Bronchiectasis: A Randomized Crossover Trial. AEs
64  2018 Impact of Previous Physical Activity Levels on Symptomatology, Functionality, and Strength during an Acute Exacerbation in COPD Patients. COPD, FIM, mMRC, PA, PI
65  2018 Maekmoondong-tang in treatment of postoperative cough in patients with lung cancer: Study protocol for a randomized, double-blind, placebo-controlled, multicenter trial. ---
66  2018 Psychometric properties of the German version of the Leicester Cough Questionnaire in sarcoidosis. HRQL
67  2018 Short- and Long-term Effects of Neuromodulators for Unexplained Chronic Cough. TCAs, UCC
68  2018 Short-Term Particulate Air Pollution Exposure is Associated with Increased Severity of Respiratory and Quality of Life Symptoms in Patients with Fibrotic Sarcoidosis. FEV1, FVC, IQR, KSQ, SGRQ
69  2018 Speech therapy in the management of difficult-to-treat chronic cough - preliminary results. VAS
70  2018 The impacts of cough: a cross-sectional study in a Finnish adult employee population. aOR
71  2018 The validity and reliability of the Turkish version of the Leicester Cough Questionnaire in COPD patients COPD, SF-36
72  2017 Association between fractional exhaled nitric oxide and clinical characteristics and outcomes in patients with subacute cough. CSS, FeNO
73  2017 Effectiveness of proton pump inhibitor in unexplained chronic cough. PPI, VAS
74  2017 Korean version of the Cough Symptom Score: clinical utility and validity for chronic cough. CI, CSS, VAS
75  2017 Long-term prognosis of chronic cough: a prospective, observational cohort study. ---
76  2017 Risk Factors for Chronic Cough Among 14,669 Individuals From the General Population. PARs
77  2017 The Assessment of Cough in a Sarcoidosis Clinic Using a Validated instrument and a Visual Analog Scale. VAS
78  2017 The relationship between the Leicester cough questionnaire, eosinophilic airway inflammation and asthma patient related outcomes in severe adult asthma. AQLQ
79  2017 Theobromine for the treatment of persistent cough: a randomised, multicentre, double-blind, placebo-controlled clinical trial. AE, QoL
80  2017 Treatment of Neurogenic Cough with Tramadol: A Pilot Study. CSI
81  2017 [Clinical observation of post-infectious cough differentiated as wind-cold retention in the lung treated with scraping therapy and xuanfei zhisou decoction]. ---
82  2016 Gastroesophageal dysmotility is associated with the impairment of cough-specific quality of life in patients with cough variant asthma. CVA, GERD, QoL
83  2016 Improved Cough and Cough-Specific Qualityof Life in Patients Treated for Scleroderma-Related Interstitial Lung Disease: Results of Scleroderma Lung Study II. CYC, FC, GERD, ILD, MMF, QoL, SSc-ILD
84  2016 Physiotherapy, and speech and language therapy intervention for patients with refractory chronic cough: a multicentre randomised control trial. HRQoL, PSALTI
85  2016 The Effects of Azithromycin in Treatment-Resistant Cough: A Randomized, Double-Blind, Placebo-Controlled Trial. ---
86  2016 The efficacy of specific neuromodulators on human refractory chronic cough: a systematic review and meta-analysis. RCTs
87  2016 The psychometric properties of the Leicester Cough Questionnaire and Respiratory Symptoms in CF tool in cystic fibrosis: A preliminary study. CF, CFQ-R, ReS-CF
88  2016 Validation of a Spanish version of the Leicester Cough Questionnaire in non-cystic fibrosis bronchiectasis. NCFBC, SGRQ
89  2016 Validation of the Polish Version of the Chronic Cough Quality of Life Questionnaire (Leicester Cough Questionnaire). QOL-Q, VAS
90  2016 Validity and reliability of the Thai version of the leicester cough questionnaire in chronic cough. BCS, QoL, SF-36
91  2015 Airway inflammation, cough and athlete quality of life in elite female cross-country skiers: A longitudinal study. REST-Q
92  2015 Efficacy of add-on montelukast in nonasthmatic eosinophilic bronchitis: the additive effect on airway inflammation, cough and life quality. BUD, CVAS, ECP, Eos, MONT, NAEB
93  2015 Pregabalin and Speech Pathology Combination Therapy for Refractory Chronic Cough: A Randomized Controlled Trial. coughVAS, CRC, QoL, SPT
94  2015 Real-world effect of gastroesophageal reflux disease on cough-related quality of life and disease status in asthma and COPD. ACT, CAT, COPD, FSSG, GERD
95  2015 Reliability and validity of a korean version of the leicester cough questionnaire. GRC, SF-36
96  2015 Short-term effects of three slow expiratory airway clearance techniques in patients with bronchiectasis: a randomised crossover trial. ACTs, AD, CI, ELTGOL, TPEP
97  2015 The relationship between cough-specific quality of life and abdominal muscle endurance, fatigue, and depression in patients with COPD. BDI, FIS
98  2015 Validation of the French version of the Leicester Cough Questionnaire in chronic obstructive pulmonary disease. CASA-Q, COPD
99  2015 Validity and Reliability of the Chronic Respiratory Disease Questionnaire in Elderly Individuals with Mild to Moderate Non-Cystic Fibrosis Bronchiectasis. CF, CRDQ, HADS, HRQoL, SGRQ
100  2015 Validity of a Spanish Version of the Leicester Cough Questionnaire in Children With Cystic Fibrosis. BMI, CF, CFQ-R, HRQoL